Institutionalizing Violence Against Women (and Men)

5 Aug

Don't Get Stuck With HIV

It is not news that injectible Depo Provera (DMPA, a hormonal contraceptive) doubles the risk of HIV negative women being infected, and doubles the risk of HIV positive women infecting their sexual partner with HIV. Nor is it news that injectible Depo is mostly used in developing countries, and among non-white people in the US. Therefore, it tends to be used in places where HIV prevalence is higher, and among populations with higher prevalence in low prevalence countries.

Why use injectible Depo when this is well known? Defenders of the product claim that using it cuts other risks, such as unplanned pregnancies, particularly among HIV positive women. They feel this mitigates the risk of transmitting the virus, or of becoming infected. Strange logic, but such is the mindset of the HIV industry, and those who (very strenuously and aggressively) defend the use of injectible Depo.

If various NGOs, public health…

View original post 396 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: